Effects of Xal-Ease on Patient Compliance With Xalatan
Not Applicable
- Conditions
- Glaucoma
- Registration Number
- NCT00573638
- Lead Sponsor
- Augusta University
- Brief Summary
The study hypothesis is that the Xal-Ease with increase patient compliance with XALATAN
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- 40 to 80 years old
- Diagnosis warranting treatment with Xalatan eye drops.
- ambulatory and well functioning
Exclusion Criteria
- non-ambulatory
- less than 40 or greater than 80 years old
- Not using Xalatan eye drops
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method The primary outcome measure is compliance with the medication XALATAN using and not using the Xal-Ease delivery aid for their glaucoma treatment. six months
- Secondary Outcome Measures
Name Time Method To determine if any of the other factors mentioned in the survey affect compliance to their medical regimen six months To see whether or not the Xal-Ease device helps patients conserve medication. ie - aids in drops not distilled in the eye. 6 months
Trial Locations
- Locations (1)
Medical College of Georgia Health Inc
🇺🇸Augusta, Georgia, United States